Adenosine, long known as a regulator of cardiovascular function, has recently been identified as a significant paracrine inhibitor of inflammation that acts primarily by activation of A2A adenosine receptors (A2AARs) on lymphoid or myeloid cells. In this issue of the JCI, Yang et al. describe a proinflammatory phenotype resulting from deletion of the gene encoding the A2B adenosine receptor (A2BAR) in the mouse, suggesting that activation of the A2BAR can also have antiinflammatory effects (see the related article beginning on page 1913). Nevertheless, the role of the A2BAR remains enigmatic since its activation can either stimulate or inhibit the release of proinflammatory cytokines in different cells and tissues.
Joel Linden
Title and authors | Publication | Year |
---|---|---|
Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome
Figarella K, Kim J, Ruan W, Mills T, Eltzschig HK, Yuan X |
Frontiers in immunology | 2024 |
Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure
Eckle T, Bertazzo J, Khatua TN, Tabatabaei SR, Bakhtiari NM, Walker LA, Martino TA |
Circulation research | 2024 |
A crucial role of neutrophil extracellular traps in pulmonary infectious diseases
Pan T, Lee JW |
Chinese Medical Journal Pulmonary and Critical Care Medicine | 2024 |